Next Article in Journal
Identification of Cytochrome P450 Enzymes Responsible for Oxidative Metabolism of Synthetic Cannabinoid (1-Hexyl-1H-Indol-3-yl)-1-naphthalenyl-methanone (JWH-019)
Previous Article in Journal
Black Phosphorus/WS2-TM (TM: Ni, Co) Heterojunctions for Photocatalytic Hydrogen Evolution under Visible Light Illumination
Previous Article in Special Issue
Ferrous Salt-Catalyzed Oxidative Alkenylation of Indoles: Facile Access to 3-Alkylideneindolin-2-Ones
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Metal-Free Photoredox Intramolecular Cyclization of N-Aryl Acrylamides

1
Key Laboratory for Green Organic Synthesis and Application of Hunan Province, Key Laboratory of Environmentally Friendly Chemistry and Application of Ministry of Education, College of Chemistry, **angtan University, **angtan 411105, China
2
Hunan Provincial Key Laboratory for Synthetic Biology of Traditional Chinese Medicine, School of Pharmaceutical Sciences, Hunan University of Medicine, Huaihua 418000, China
3
School of Chemistry and Chemical Engineering, Henan Normal University, **nxiang 453007, China
*
Authors to whom correspondence should be addressed.
Catalysts 2023, 13(6), 1007; https://doi.org/10.3390/catal13061007
Submission received: 30 April 2023 / Revised: 27 May 2023 / Accepted: 12 June 2023 / Published: 14 June 2023
(This article belongs to the Special Issue Radical-Mediated Functionalization of Alkenes)

Abstract

:
A novel metal-free photoredox-catalyzed cyclization reaction of N-aryl acrylamide is herein reported that provides synthetically valuable oxindole derivatives through the bis-mediation of H2O and aldehyde. In this work, sustainable visible light was used as the energy source, and the organic light-emitting molecule 4CzIPN served as the efficient photocatalyst. The main characteristics of this reaction are environmentally friendly and high yields.

1. Introduction

Oxindole is a highly important skeleton that widely exists in biologically active compounds such as naturally occurring products [1] and drugs [2]. Specifically, oxindole compounds represent an important class of drugs with antibiotic, anticancer, antiviral, and other activities [3,4,5]. For example, ubrogepant [6], a drug for the treatment of migraine, contains a 3-cyclopentyl spiro-7-azaoxindole core. Rhynchophylline [7], which inhibits the activity of peripheral vascular contraction, could reduce vascular resistance and blood pressure and have the effect of anti-platelet aggregation and anti-thrombus (Figure 1).
Because of the pharmaceutical significance of oxindoles [8,9,10], the construction of this motif has attracted considerable attention among synthetic chemists [11,12,13]. In the past few years, many functional groups have been installed successfully to oxindoles through the treatment of NBS [14], AgSCN [15], 2,4-pentanedione [16], and AIBN [17]. However, these strategies required stoichiometric amounts of functionalized reagents, high metal catalyst loading, strong oxidant and elevated temperature for high reaction efficiency. On the other hand, as one of the most attractive topics in organic chemistry, hydroarylation process has drawn interest of chemists in the past decades [18,19,20,21,22,23,24]. Recently, Pan and our group [25,26] independently reported a visible-light-induced hydrocyclization of unactivated alkenes which generated the polycyclic quinazolinones. (Figure 2a). Photochemical radical addition and cyclization of N-arylacrylamide provide reliable access to a range of functionalized oxindoles [27,28,29,30,31,32,33,34,35,36,37]. Alternatively, our group reported visible light-induced photocatalytic systems for intramolecular hydroarylation of N-arylacrylamide by proton-coupled electron transfer (PCET) process [38] and energy transfer [39] (Figure 2b). However, this reaction requires the addition of strong acids and chlorobenzene as reaction solvent, which limits the substrate scope and further synthetic application. Inspired by these cyclizations of alkene studies, we envision an acid-free visible-light-mediated photocyclization strategy from N-aryl acrylamide to access oxindole skeletons. (Figure 2c). In our recent findings of redox-neutral radical addition and cyclization of N-arylacrylamides with benzaldehydes [40], aliphatic aldehydes did not proceed through the coupling, probably because of the higher reductive potential of them than aromatic aldehydes [41]. Instead, the hydroarylation oxindole product was accessed in moderate yield when pivalaldehyde was exploited in this system. This result encouraged us to explore an acid-free hydroarylation process of N-aryl acrylamide, which was herein reported.

2. Results and Discussion

Therefore, the optimization studies were performed by selecting N-methly-N-phenylmethacrylamide (1a) as the standard reactant. Initially, when the cyclization reaction was performed using 4CzIPN as photocatalyst (PC) along with decanal as additive in water/toluene mixed solvent under a 36 W blue LED at argon atmosphere (Table 1, entry 1), the desired product 2a was obtained in 80% yield. Then, this reaction was independently conducted in the absence of light irradiation (Table 1, entry 2, 0%), water (Table 1, entry 3, yield 17%), PC (Table 1, entry 4, 0%) and aldehydes (Table 1, entry 5, 0%). These control experiments demonstrated the critical role of visible light, photocatalyst and aldehyde and the promotional effect of H2O. We next moved on to screen photocatalysts include Rose bengal (Table 1, entry 6), Mes2AcrtBu2BF4 (Table 1, entry 7), Xanthone (Table 1, entry 8), and 9-Fluorenone (Table 1, entry 9), and found that those PCs were all ineffective. However, neutral Eosin Y showed also a good efficiency (Table 1, entry 10, yield 73%). Other solvents such as THF, DMF, EtOAc, NMP and CH3CN (Table 1, entry 11–16) were investigated, all of which showed inferior results as compared with toluene. PhCl (Table 1, entry 17) and o-Xylene (Table 1, entry 18) showed moderate yields (65% and 70% yields, respectively). Furthermore, the screening of other aldehyde additives such as 3-phenylpropanal, propionaldehyde, cyclohexanecarbaldehyde, pivalaldehyde, and glutaraldehyde, afforded the cyclization product with slightly reduced yields (Table 1, entries 19–23). Finally, decreasing the photocatalyst loading to 2 mol% resulted in 60% yield of products, with significant amounts of 1a remained (Table 1, entry 24).
With the optimized reaction condition in hand, we next explored the substrate scope of the photocyclization reaction of N-arylacrylamides (Figure 3). Generally, a broad range of N-arylacrylamides with various functional groups were subjected and found compatible with this system. The halo-substituted N-methyl-N-phenylmethacrylamides were carried out with the photochemical reaction, leading to the corresponding halo-substituted (such as -Cl, -Br, -I) oxindoles in moderate yields (Figure 3, 2b, 2c, 2d, 35–45% yields), along with the formation of the dihydroquinolines in a trace amount. When alkyl groups such as methyl and tert-butyl were attached, the cyclization products were obtained in excellent yields (Figure 3, 2e–2h, yields 74–89%). As a comparison, para-, meta-, and ortho- substituted compounds were successfully tested and the position of these substituents had little impact on the yield. Notably, meta-substituted N-aryl acrylamide was viable under standard conditions to give the desired product with poor regioselectivity (2g). Introducing a benzyl substituent in the α-position of acrylamides did not have obviously deleterious effects on the reaction yield (2i, 85% yield). The reactants with various N-protecting functional groups including phenyl, ethyl, isopropyl and cyclohexyl generated the corresponding products in generally good yields (2j, 90% yield, 2l, 82% yield, 2m, 78% yield, 2o, 83% yield). The benzyl protective group (2k) is well tolerated with 70% yield, which could be converted to NH oxindole by debenzylation. In addition, the reaction was extended to phenyl ether, leading to 2n in a modest yield. Then, the reaction systems were found to tolerate the substrate attached with drug molecule such as naproxen (2p, 72% yield). Cyclic and diaryl N-acylamines were exploited to smoothly produce the polycyclic products (2q–2s) and N-aryl oxindoles (2q) with yield ranging from 65% to 73%. While our 4CzIPN/decanal catalytic system enabled exclusive 5-exo-trig selectivity for most of the above reactants, N-methyl-N-arylcinnamamides (1t) afforded the corresponding 4-arylquinolinone as the major product (3t, 83%). When the reactants contain strong electron-absorbing groups and partial non-terminal alkenyl, the reaction cannot be performed effectively (See Supplementary Materials for details).
Because of the superior electrocyclization reactivity, the π-extension substrates such as biphenyl acrylamide (1u) and N-(4-methoxyphenyl)-N-methylmethacrylamide (1v) led to the formation of 3,4-dihydroquinolinones as the major products in the current systems (3u and 3v). Besides, we changed the equivalent amounts of the decanal to explore the site-selectivity control for 6-endo-trig vs. 5-exo-trig cyclization of N-([1,1′-biphenyl]-4-yl)-N-methylmethacrylamide. While exclusive 6-endo-trig selectivity was observed in the absence of aldehyde additives, the 5-exo-trig cyclization process was enhanced when increasing the amount of decanal (Figure 4). The results indicate that the addition of aldehyde additives in the systems could alter the reaction pathways over 5-exo-trig cyclization.
Next, control experiments were conducted to gain mechanistic insights into the present aldehyde-promoted hydroarylation reaction (Scheme 1). The addition of the radical scavenger 2,2,6,6- tetramethylpiperidin-1-oxyl (TEMPO) or 1,1-diphenylethylene (DPE) to the standard conditions caused complete quenching in the yield of 2a (Scheme 1a). The H/D exchange experiments show that when D5-labeled N-acylaniline (D5-1a) was used, no D incorporation of cyclized products was observed. Comparably, the addition of D2O led to 83% incorporation of D into newly formed methyl groups (Scheme 1b), indicating the hydrogen in the reaction being derived from water. The control experiment with 3-phenylpropanal under the standard conditions within 24 h furnished the oxindole product 2a in 59% yield, along with the detection of both 3-phenylpropanoic acid and 3-phenylpropan-1-ol. This result suggests the by-product formation from aliphatic aldehyde. The Stern−Volmer quenching experiments indicate that while the acrylamide 1a had not fluorescence quenching effect, the decanal additive quenched slightly the fluorescence emission of excited 4CzIPN (KSV = 54.9, Scheme 1d). Our previous work had also demonstrated that the substrate 1v (KSV = 41.3) and 1t (KSV = 912.4) show also quenching effect, which could be attributed to energy transfer [36]. Finally, the results of the light on/off experiment showed that the present reaction was a continuous illumination reaction (See Supplementary Materials for details).
On the basis of above results of mechanistic studies and previous reports, a possible reaction mechanism involving basically consecutive photoinduced electron transfer (ConPET) [40,42] was proposed (Scheme 2). The 4CzIPN photocatalyst absorbs photon to generate its excited state PC*, which oxidize the aldehydes to give PC anion radical and acyl radical A. The second irradiation of it occurs to afford the excited state of PC anion radical. This highly reductive species (Ered < −2.9 V vs. SCE) [43] undergoes single electron transfer with acrylamide 1a (Ered = −2.45 V vs. SCE) with the assistance of proton to produce the radical species B. The subsequent intramolecular radical cyclization, single electron transfer, and deprotonation sequentially proceed to afford the final product 2a. The formation of 3-phenylpropanoic acid and 3-phenylpropan-1-ol can be attributed to the further oxidization of acyl radical and two electron reduction of aldehyde, respectively. We suspect that aliphatic aldehydes have higher reductive potential so that they are easier to be oxidized by the excited photocatalyst.

3. Materials and Methods

3.1. Materials and Chemicals

All reactions were carried out under an atmosphere of nitrogen unless otherwise noted. Colum chromatography was performed using silica gel (200–300 mesh) and thin layer chromatography was performed using silica gel (GF254). 1H NMR and 13C NMR spectra were recorded on Bruker-AV (400 and 100 MHz, respectively) instrument using CDCl3, acetone-d6 or dimethyl sulfoxide-d6 as solvent. Mass spectra were measured on Agilent 5975 GC-MS instrument (EI). High-resolution mass spectra (ESI) were obtained with the Thermo Scientific LTQ Orbitrap XL mass spectrometer. The structures of known compounds were further corroborated by comparing their 1H NMR, 13C NMR data and HRMS data with those of literature. Melting points were measured with a YUHUA X-5 melting point instrument and were uncorrected. Reagents were used as received or prepared in our laboratory.

3.2. General Procedure for Hydroarylation (Standard Conditions)

A 10 mL vial was charged with N-methly-N-phenylmethacrylamide (1a, 35 mg, 0.2 mmol), 4CzIPN (5 mg, 0.006 mmol), decanal (32 mg, 0.2 mmol), H2O (0.4 mL), toluene (1 mL). The atmosphere was exchanged by applying vacuum and backfilling with Ar (this process was conducted for three times). The resulting mixture was stirred at 2000 RPM for 48 h under irradiation with a 36 W blue LED. The crude reaction mixture was quenched with saturated sodium carbonate and extracted with ethyl acetate (3 × 20 mL). The extracts were combined, dried over sodium sulfate, filtered and the volatiles were removed under reduced pressure. The reaction yield was quantified by separation, and then column chromatography was performed using silica gel (200–300 mesh) or thin layer chromatography was performed using silica gel (GF254) to give product 2a.

3.3. Characterization Data of Products

1,3,3-trimethylindolin-2-one (2a) 38
Catalysts 13 01007 i003
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield 2a (28 mg, 80%) as a colorless liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.29–7.23 (m, 1H), 7.20 (d, J = 7.3 Hz, 1H), 7.06 (t, J = 7.5 Hz, 1H), 6.84 (d, J = 7.8 Hz, 1H), 3.21 (s, 3H), 1.37 (s, 6H). 13C NMR (101 MHz, Chloroform-d) δ 181.4, 142.6, 135.8, 127.7, 122.5, 122.3, 108.0, 44.2, 26.23, 24.4.
5-chloro-1,3,3-trimethylindolin-2-one (2b) and 6-chloro-1,3-dimethyl-3,4-dihydroquinolin-2(1H)-one (8.8:1) (3b) 38
Catalysts 13 01007 i004
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield mixture of 2b and 3b (19 mg, 45%) as a colorless liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.23 (dd, J = 8.2, 2.1 Hz, 1H), 7.17 (d, J = 2.0 Hz, 1H), 6.76 (d, J = 8.2 Hz, 1H), 3.32 (s, 0.3H), 3.20 (s, 3H), 2.90 (dd, J = 14.1, 4.3 Hz, 0.16H), 2.76–2.50 (m, 0.32H), 1.36 (s, 6H). 13C NMR (101 MHz, Chloroform-d) δ 180.8, 141.2, 137.5, 127.9, 127.6, 122.9, 108.9, 44.5, 26.3, 24.3.
5-bromo-1,3,3-trimethylindolin-2-one (2c) and 6-bromo-1,3-dimethyl-3,4-dihydroquinolin-2(1H)-one (4.5:1) (3c) 38
Catalysts 13 01007 i005
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield mixture of 2c and 3c (23 mg, 46%) as a colorless liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.38 (dd, J = 8.3, 1.8 Hz, 1H), 7.31 (d, J = 1.8 Hz, 1H), 6.72 (d, J = 8.2 Hz, 1H), 3.33 (s, 0.67H), 3.19 (s, 3H), 2.90 (dd, J = 14.3, 4.4 Hz, 0.18H), 2.74–2.56 (m, 0.39H), 1.36 (s, 6H). 13C NMR (101 MHz, Chloroform-d) δ 180.7, 141.7, 137.9, 130.5, 130.2, 125.7, 116.1, 115.2, 109.51, 44.4, 35.3, 32.9, 29.9, 26.3, 24.3, 15.7.
5-iodo-1,3,3-trimethylindolin-2-one (2d) and 6-iodo-1,3-dimethyl-3,4-dihydroquinolin-2(1H)-one (3.8:1) (3d) 38
Catalysts 13 01007 i006
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield mixture of 2d and 3d (21 mg, 35%) as a colorless liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.58 (d, J = 8.2 Hz, 1H), 7.48 (s, 1H), 6.63 (d, J = 8.1 Hz, 1H), 3.32 (s, 0.79H), 3.19 (s, 3H), 3.08–2.77 (m, 0.39H), 2.71–2.59 (m, 0.52H), 1.36 (s, 6H). 13C NMR (101 MHz, Chloroform-d) δ 180.6, 142.4, 138.3, 136.5, 131.3, 120.4, 116.5, 110.1, 85.7, 85.1, 44.3, 35.3, 32.8, 29.8, 26.3, 24.3, 15.6.
5-(tert-butyl)-1,3,3-trimethylindolin-2-one (2e) and 6-(tert-butyl)-1,3-dimethyl-3,4-dihydroquinolin-2(1H)-one (4.5:1) (3e) 38
Catalysts 13 01007 i007
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield mixture of 2e and 3e (41 mg, 89%) as a colorless liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.32–7.23 (m, 2H), 6.78 (d, J = 8.1 Hz, 1H), 3.35 (s, 0.67H), 3.21 (s, 3H), 2.92 (dd, J = 14.5, 4.9 Hz, 0.23H), 2.80–2.40 (m, 0.46H), 1.38 (s, 6H), 1.33 (d, J = 6.1 Hz, 12H). 13C NMR (101 MHz, Chloroform-d) δ 145.8, 140.3, 135.6, 124.2, 119.4, 107.4, 44.4, 34.6, 31.7, 31.4, 26.2, 24.5.
1,3,3,5-tetramethylindolin-2-one (2f) and 1,3,6-trimethyl-3,4-dihydroquinolin-2(1H)-one (2.6:1) (3f) 38
Catalysts 13 01007 i008
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield mixture of 2f and 3f (31 mg, 82%) as a colorless liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.08–7.00 (m, 2H), 6.73 (d, J = 7.8 Hz, 1H), 3.33 (s, 1.17H), 3.19 (s, 3H), 2.93–2.83 (m, 0.38H), 2.71–2.50 (m, 0.85H), 2.69–2.57 (m, 1H), 2.35 (s, 3H), 2.30 (s, 1.14H), 1.35 (s, 6H), 1.24 (d, J = 6.7 Hz, 1.64H). 13C NMR (101 MHz, Chloroform-d) δ 181.3, 140.2, 135.8, 132.1, 131.9, 128.6, 127.8, 123.1, 114.3, 107.7, 44.2, 35.5, 33.2, 29.7, 26.2, 24.4, 21.1, 20.5, 15.7.
1,3,3,4-tetramethylindolin-2-one (2g) and 1,3,3,6-tetramethylindolin-2-one (2:1) (2g’)1
Catalysts 13 01007 i009
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield 2g + 2g′ (29 mg, 76%) as a colorless liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.16 (t, J = 7.6 Hz, 0.68H),7.08 (d, J = 7.6 Hz, 0.34H), 6.87 (d, J = 7.6 Hz, 0.34H), 6.83 (d, J = 7.6 Hz, 0.68H), 6.70 (d, J = 8.1 Hz, 1H), 3.20 (s, 3H), 2.40 (s, 2H), 2.39 (s, 1H), 1.45 (s, 4H), 1.35 (s, 2H). 13C NMR (101 MHz, Chloroform-d) δ 181.7, 181.4, 142.9, 142.7, 134.1, 133.0, 132.6, 127.5, 125.0, 122.9, 122.0, 109.0, 105.8, 45.0, 44.0, 26.3, 24.5, 22.4, 21.8, 18.1.
1,3,3,7-tetramethylindolin-2-one (2h) 38
Catalysts 13 01007 i010
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield 2h (28 mg, 74%) as a colorless liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.05 (d, J = 8.0 Hz, 1H), 6.96 (dt, J = 14.7, 7.1 Hz, 2H), 3.50 (s, 3H), 2.59 (s, 3H), 1.35 (s, 6H). 13C NMR (101 MHz, Chloroform-d) δ 182.1, 140.4, 136.5, 131.4, 122.4, 120.2, 119.7, 43.5, 29.6, 24.8, 19.1.
3-benzyl-1,3-dimethylindolin-2-one (2i) 38
Catalysts 13 01007 i011
Prepared according to standard conditions within 96 h. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield 2i (43 mg, 85%) as a solid. mp: 87–90 °C. 1H NMR (400 MHz, Chloroform-d) δ 7.18 (t, J = 8.3 Hz, 1H), 7.13 (d, J = 6.6 Hz, 1H), 7.10–6.98 (m, 4H), 6.85 (dd, J = 7.2, 2.1 Hz, 2H), 6.62 (d, J = 7.7 Hz, 1H), 3.12 (d, J = 13.0 Hz, 1H), 3.01 (d, J = 13.0 Hz, 1H), 2.99 (s, 3H), 1.48 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 178.0, 143.1, 136.2, 133.0, 129.8, 127.8, 127.5, 126.4, 123.3, 122.1, 107.8, 50.0, 44.6, 25.9, 22.8.
3,3-dimethyl-1-phenylindolin-2-one (2j) 38
Catalysts 13 01007 i012
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield 2j (36 mg, 75%) as a solid. mp: 84–86 °C. 1H NMR (400 MHz, Chloroform-d) δ 7.53 (t, J = 7.7 Hz, 2H), 7.44–7.39 (m, 3H), 7.29 (d, J = 7.3 Hz, 1H), 7.20 (t, J = 8.2 Hz, 1H), 7.11 (t, J = 7.2 Hz, 1H), 6.86 (d, J = 7.8 Hz, 1H), 1.51 (s, 6H). 13C NMR (101 MHz, Chloroform-d) δ 180.7, 142.5, 135.7, 134.7, 129.6, 127.9, 127.6, 126.6, 123.0, 109.4, 44.3, 24.8.
1-benzyl-3,3-dimethylindolin-2-one (2k) 38
Catalysts 13 01007 i013
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield 2k (35 mg, 70%) as a colorless liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.33–7.25 (m, 5H), 7.22 (d, J = 8.1 Hz, 1H), 7.14 (t, J = 8.3 Hz, 1H), 7.03 (t, J = 7.5 Hz, 1H), 6.73 (d, J = 7.7 Hz, 1H), 4.93 (s, 2H), 1.45 (s, 6H). 13C NMR (101 MHz, Chloroform-d) δ 181.5, 141.7, 136.1, 135.8, 128.8, 127.6, 127.2, 122.5, 122.4, 109.1, 44.2, 43.6, 24.6.
1-isopropyl-3,3-dimethylindolin-2-one (2l) 38
Catalysts 13 01007 i014
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield 2l (35 mg, 88%) as a colorless liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.20 (d, J = 7.9 Hz, 2H), 7.03 (t, J = 7.3 Hz, 2H), 4.71–4.61 (m, 1H), 1.47 (d, J = 7.1 Hz, 6H), 1.34 (s, 6H). 13C NMR (101 MHz, Chloroform-d) δ 181.1, 136.4, 127.3, 122.5, 121.9, 109.9, 43.8, 43.4, 24.0, 19.4.
1-ethyl-3,3-dimethylindolin-2-one (2m) 38
Catalysts 13 01007 i015
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield 2m (29 mg, 78%) as a colorless liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.28–7.18 (m, 2H), 7.05 (t, J = 7.4 Hz, 1H), 6.87 (d, J = 7.8 Hz, 1H), 3.77 (q, J = 7.2 Hz, 2H), 1.36 (s, 6H), 1.26 (t, J = 7.2 Hz, 3H). 13C NMR (101 MHz, Chloroform-d) δ 180.9, 141.6, 136.0, 127.5, 122.4, 122.2, 108.1, 44.0, 34.4, 24.3, 12.7.
3,3-dimethyl-1-(2-phenoxyethyl)indolin-2-one (2n) 38
Catalysts 13 01007 i016
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield 2n (37 mg, 66%) as a colorless liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.31–7.19 (m, 4H), 7.08 (t, J = 8.4 Hz, 2H), 6.94 (t, J = 7.4 Hz, 1H), 6.87 (d, J = 8.7 Hz, 2H), 4.23 (t, J = 5.6 Hz, 2H), 4.14 (t, J = 5.6 Hz, 2H), 1.39 (s, 6H). 13C NMR (101 MHz, Chloroform-d) δ 181.7, 158.4, 142.2, 135.7, 127.6, 122.5, 122.4, 121.1, 114.5, 109.0, 65.4, 44.1, 24.5.
1-cyclohexyl-3,3-dimethylindolin-2-one (2o) 38
Catalysts 13 01007 i017
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield 2o (40 mg, 83%) as a colorless liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.25–7.17 (m, 2H), 7.06 (d, J = 7.8 Hz, 1H) 7.02 (t, J = 7.7 Hz, 1H), 4.24–4.11 (m, 1H), 2.22–2.08 (m, 2H), 1.89 (d, J = 13.3 Hz, 2H), 1.80–1.68 (m, 3H), 1.48–1.26 (m, 9H). 13C NMR (101 MHz, Chloroform-d) δ 181.2, 141.6, 136.4, 127.3, 122.5, 121.8, 110.1, 51.9, 43.8, 29.2, 26.0, 25.5, 24.6.
2-(3,3-dimethyl-2-oxoindolin-1-yl)ethyl 2-(6-methoxynaphthalen-2-yl)propanoate (2p) 38
Catalysts 13 01007 i018
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 3/1) to yield 2q (60 mg, 72%) as a colorless liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.67–7.60 (m, 2H), 7.53 (s, 1H), 7.31–7.25 (m, 1H), 7.18–7.07 (m, 4H), 7.02 (t, J = 7.1 Hz, 1H), 6.80 (d, J = 7.7 Hz, 1H), 4.41–4.23 (m, 2H), 4.03–3.82 (m, 5H), 3.75 (q, J = 7.1 Hz, 1H), 1.48 (d, J = 7.2 Hz, 3H), 1.31 (s, 3H), 1.28 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 181.5, 174.5, 157.6, 141.8, 135.7, 135.3, 133.7, 129.3, 127.6, 126.0, 122.5, 122.4, 119.0, 108.4, 105.5, 61.9, 55.4, 45.4, 44.0, 38.9, 18.3.
2,2-dimethyl-6,7-dihydrobenzo [6,7]azepino [3,2,1-hi]indol-1(2H)-one (2q) 38
Catalysts 13 01007 i019
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield 2p (34 mg, 65%) as a solid. mp: 185–188 °C. 1H NMR (400 MHz, Chloroform-d) δ 7.83 (d, J = 8.2 Hz, 1H), 7.31–7.25 (m, 1H), 7.23–7.14 (m, 2H), 7.12 (dd, J = 6.3, 2.2 Hz, 1H), 7.05–6.96 (m, 2H), 3.20–2.92 (m, 4H), 1.49 (s, 6H). 13C NMR (101 MHz, Chloroform-d) δ 181.8, 139.7, 136.7, 136.2, 136.1, 129.5, 126.5, 126.3, 126.2, 125.1, 122.4, 120.2, 43.9, 34.0, 33.7, 29.7, 25.2.
7,7-dimethyl-1,2,3,4-tetrahydroazepino [3,2,1-hi]indol-6(7H)-one (2r) 38
Catalysts 13 01007 i020
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield 2r (31 mg, 73%) as a colorless liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.04 (dd, J = 6.9, 1.5 Hz, 1H), 6.99–6.90 (m, 2H), 4.03–3.88 (m, 2H), 3.03–2.88 (m, 2H), 2.09–1.95 (m, 4H), 1.36 (s, 6H). 13C NMR (101 MHz, Chloroform-d) δ 181.8, 141.3, 136.2, 129.0, 125.2, 122.3, 120.1, 44.2, 40.9, 30.9, 26.5, 26.4, 24.7.
1,1-dimethyl-5,6-dihydro-4H-pyrrolo [3,2,1-ij]quinolin-2(1H)-one (2s) 38
Catalysts 13 01007 i021
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield 2s (28 mg, 70%) as a colorless liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.06–6.99 (m, 2H), 6.97–6.92 (m, 1H), 3.75–3.69 (m, 2H), 2.79 (t, J = 6.1 Hz, 2H), 2.01 (p, J = 6.0 Hz, 2H), 1.37 (s, 6H). 13C NMR (101 MHz, Chloroform-d) δ 180.3, 138.5, 134.4, 126.4, 121.9, 120.1, 45.6, 38.8, 24.7, 24.2, 21.2.
1-methyl-4-phenyl-3,4-dihydroquinolin-2(1H)-one (3t) 39
Catalysts 13 01007 i022
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield 2t (39 mg, 83%) as a colorless liquid. 1H NMR (400 MHz, Chloroform-d) δ 7.37–7.25 (m, 5H), 7.17 (d, J = 7.1 Hz, 2H), 7.07 (d, J = 7.9 Hz, 1H), 7.03–6.98 (m, 1H), 6.93 (d, J = 7.4 Hz, 1H), 4.24 (t, J = 7.3 Hz, 1H), 3.40 (s, 3H), 3.02–2.90 (m, 2H). 13C NMR (101 MHz, Chloroform-d) δ 169.3, 141.0, 140.3, 129.1, 128.8, 128.0, 127.8, 127.7, 127.1, 123.0, 114.8, 41.4, 38.8, 29.5.
1,3-dimethyl-6-phenyl-3,4-dihydroquinolin-2(1H)-one (3u)39
Catalysts 13 01007 i023
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield 2u (47 mg, 94%) as a colorless solid.mp: 95–98 °C. 1H NMR (400 MHz, Chloroform-d) δ 7.58 (d, J = 7.7 Hz, 2H), 7.53–7.39 (m, 5H), 7.34 (t, J = 7.3 Hz, 1H), 7.04 (d, J = 8.4 Hz, 1H), 3.40 (s, 3H), 3.26 (s, 0.44H), 3.00 (dd, J = 14.8, 5.1 Hz, 0.98H), 2.81–2.62 (m, 2.07H), 1.43 (s, 0.91H), 1.30 (d, J = 6.7 Hz, 3H). 13C NMR (101 MHz, Chloroform-d) δ 173.1, 140.2, 139.6, 135.6, 128.8, 127.1, 126. 7, 126.5, 125.9, 114.8,108.2, 35.5, 33.4, 29.8, 24.4, 15.7.
6-methoxy-1,3-dimethyl-3,4-dihydroquinolin-2(1H)-one (3v)39
Catalysts 13 01007 i024
Prepared according to standard conditions. Purification by thin layer chromatography was performed (PE/EA: 6/1) to yield 2u (21 mg, 95%) as a colorless solid.mp: 75–76 °C. 1H NMR (400 MHz, Chloroform-d) δ 6.85 (d, J = 8.8 Hz, 1H), 6.75 (dd, J = 8.7, 2.9 Hz, 1H), 6.72–6.69 (m, 1H), 3.77 (s, 1H), 3.76 (s, 3H), 3.30 (s, 3H), 3.16 (s, 0.36H), 2.90–2.83 (m, 1H), 2.67–2.54 (m, 2H), 1.34 (s, 0.9H), 1.22 (d, J = 6.6 Hz, 3H). 13C NMR (101 MHz, Chloroform-d) δ 172.7, 155.2, 133.9, 127.1, 115.3, 114.1, 76.9, 55.5, 35.4, 33.5, 29.9, 24.4, 15.6.

4. Conclusions

In summary, we have developed a mild acid- and metal-free photoredox system that enables highly efficient hydroarylation and cyclization of N-arylacrylamides. In this system, aliphatic aldehyde was used instead of strong acid and bromide additive which makes it milder and easier to handle and has probably broader potential applications in the synthesis of more complex compounds.

Supplementary Materials

The following supporting information can be downloaded at: https://mdpi.longhoe.net/article/10.3390/catal13061007/s1, detailed experiments, mechanistic studies, and NMR spectra of all products.

Author Contributions

Conceptualization, H.H.; experimental investigation, Z.L.; writing—original draft preparation, Z.L. and H.H.; writing—review and editing, X.J., F.Z. and G.D.; supervision, F.Z. and H.H. All authors have read and agreed to the published version of the manuscript.

Funding

The authors would like to acknowledge the National Natural Science Foundation of China (22071211, 21801076), the Scientific Research Fund of Education Department of Hunan Province (21A0079), the Postgraduate Scientific Research Innovation Project of Hunan Province (CX20220594), and Open Research Fund of School of Chemistry and Chemical Engineering of Henan Normal University (2022C02).

Data Availability Statement

The data that support the findings in the work are available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Khetmalis, Y.M.; Shivani, M.; Murugesan, S.; Chandra Sekhar, K.V.G. Oxindole and its derivatives: A review on recent progress in biological activities. Biomed. Pharm. 2021, 141, 111842. [Google Scholar] [CrossRef] [PubMed]
  2. Kaur, M.; Singh, M.; Chadha, N.; Silakari, O. Oxindole: A chemical prism carrying plethora of therapeutic benefits. Eur. J. Med. Chem. 2016, 123, 858–894. [Google Scholar] [CrossRef] [PubMed]
  3. Lai, J.Y.; Cox, P.J.; Patel, R.; Sadiq, S.; Aldous, D.J.; Thurairatnam, S.; Smith, K.; Wheeler, D.; Jagpal, S.; Parveen, S.; et al. Potent small molecule inhibitors of spleen tyrosine kinase (Syk). Bioorg. Med. Chem. Lett. 2003, 13, 3111–3114. [Google Scholar] [CrossRef]
  4. Yasuda, D.; Takahashi, K.; Ohe, T.; Nakamura, S.; Mashino, T. Antioxidant activities of 5-hydroxyoxindole and its 3-hydroxy-3-phenacyl derivatives: The suppression of lipid peroxidation and intracellular oxidative stress. Bioorg. Med. Chem. 2013, 21, 7709–7714. [Google Scholar] [CrossRef]
  5. Yong, S.R.; Ung, A.T.; Pyne, S.G.; Skelton, B.W.; White, A.H. Synthesis of novel 3′-spirocyclic-oxindole derivatives and assessment of their cytostatic activities. Tetrahedron 2007, 63, 5579–5586. [Google Scholar] [CrossRef] [Green Version]
  6. Scott, L.J. Ubrogepant: First Approval. Drugs 2020, 80, 323–328. [Google Scholar] [CrossRef] [Green Version]
  7. Dandia, A.; Khan, S.; Soni, P.; Indora, A.; Mahawar, D.K.; Pandya, P.; Chauhan, C.S. Diversity-oriented sustainable synthesis of antimicrobial spiropyrrolidine/thiapyrrolizidine oxindole derivatives: New ligands for a metallo-beta-lactamase from Klebsiella pneumonia. Bioorg. Med. Chem. Lett. 2017, 27, 2873–2880. [Google Scholar] [CrossRef]
  8. Boddy, A.J.; Bull, J.A. Stereoselective synthesis and applications of spirocyclic oxindoles. Org. Chem. Front. 2021, 8, 1026–1084. [Google Scholar] [CrossRef]
  9. **, Y.; Wang, L.; Zhang, W.; Wu, H.; Zhang, J. Enantioselective Friedel-Crafts Reaction of Indoles with Isatins Catalyzed by Cinchona Alkaloid Silyl Ether Derivative. Chin. J. Org. Chem. 2021, 41, 612–616. [Google Scholar] [CrossRef]
  10. Zhou, M.; Sun, J.; Chen, Y.; **g, Q.; Gao, Q. Decarboxylative Amidation of Acrylamides with Oxamic Acids. Chin. J. Org. Chem. 2022, 42, 257–265. [Google Scholar] [CrossRef]
  11. Li, C.C.; Yang, S.D. Various difunctionalizations of acrylamide: An efficient approach to synthesize oxindoles. Org. Biomol. Chem. 2016, 14, 4365–4377. [Google Scholar] [CrossRef]
  12. Sakla, A.P.; Kansal, P.; Shankaraiah, N. Syntheses and reactivity of spiro-epoxy/aziridine oxindole cores: Developments in the past decade. Org. Biomol. Chem. 2020, 18, 8572–8596. [Google Scholar] [CrossRef]
  13. Kokai, E.; Simig, G.; Volk, B. Literature Survey and Further Studies on the 3-Alkylation of N-Unprotected 3-Monosubstituted Oxindoles. Practical Synthesis of N-Unprotected 3,3-Disubstituted Oxindoles and Subsequent Transformations on the Aromatic Ring. Molecules 2016, 22, 24. [Google Scholar] [CrossRef]
  14. Li, D.; Shen, X. Iron- or copper-catalyzed cascade chloromethylation of activated alkenes: Efficient access to chlorinated oxindoles. Tetrahedron Lett. 2020, 61, 152316. [Google Scholar] [CrossRef]
  15. Kong, D.L.; Du, J.X.; Chu, W.M.; Ma, C.Y.; Tao, J.Y.; Feng, W.H. Ag/Pyridine Co-Mediated Oxidative Arylthiocyanation of Activated Alkenes. Molecules 2018, 23, 2727. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Wang, H.; Guo, L.N.; Duan, X.H. Silver-catalyzed oxidative coupling/cyclization of acrylamides with 1,3-dicarbonyl compounds. Chem. Commun. 2013, 49, 10370–10372. [Google Scholar] [CrossRef] [PubMed]
  17. Wei, W.; Wen, J.; Yang, D.; Guo, M.; Tian, L.; You, J.; Wang, H. Copper-catalyzed cyanoalkylarylation of activated alkenes with AIBN: A convenient and efficient approach to cyano-containing oxindoles. RSC Adv. 2014, 4, 48535–48538. [Google Scholar] [CrossRef]
  18. Gansauer, A.; von Laufenberg, D.; Kube, C.; Dahmen, T.; Michelmann, A.; Behlendorf, M.; Sure, R.; Seddiqzai, M.; Grimme, S.; Sadasivam, D.V.; et al. Mechanistic study of the titanocene(III)-catalyzed radical arylation of epoxides. Chem.-Eur. J. 2015, 21, 280–289. [Google Scholar] [CrossRef]
  19. Muhlhaus, F.; Weissbarth, H.; Dahmen, T.; Schnakenburg, G.; Gansauer, A. Merging Regiodivergent Catalysis with Atom-Economical Radical Arylation. Angew. Chem. Int. Ed. 2019, 58, 14208–14212. [Google Scholar] [CrossRef] [Green Version]
  20. Chi, Z.; Gao, Y.; Yang, L.; Zhou, C.; Zhang, M.; Cheng, P.; Li, G. Dearomative spirocyclization via visible-light-induced reductive hydroarylation of non-activated arenes. Chin. Chem. Lett. 2022, 33, 225–228. [Google Scholar] [CrossRef]
  21. Gonda, Z.; Béke, F.; Tischler, O.; Petró, M.; Novák, Z.; Tóth, B.L. Erythrosine B Catalyzed Visible-Light Photoredox Arylation-Cyclization of N-Alkyl-N-aryl-2-(trifluoromethyl)acrylamides to 3-(Trifluoromethyl)indolin-2-one Derivatives. Eur. J. Org. Chem. 2017, 2017, 2112–2117. [Google Scholar] [CrossRef] [Green Version]
  22. Lu, M.; Liu, Z.; Zhang, J.; Tian, Y.; Qin, H.; Huang, M.; Hu, S.; Cai, S. Synthesis of oxindoles through trifluoromethylation of N-aryl acrylamides by photoredox catalysis. Org. Biomol. Chem. 2018, 16, 6564–6568. [Google Scholar] [CrossRef] [PubMed]
  23. Yan, W.; Qu, Z.; Zhao, F.; Deng, G.J.; Mao, G.J.; Huang, H. Visible-Light-Induced Photoredox Dehydrative Coupling/Cyclization of N-Arylacrylamides with Hydroxyketones. Adv. Synth. Catal. 2023, 365, 612–617. [Google Scholar] [CrossRef]
  24. Zhu, M.; You, Q.; Li, R. Synthesis of CF2H-containing oxindoles via photoredox-catalyzed radical difluoromethylation and cyclization of N-arylacrylamides. J. Fluor. Chem. 2019, 228, 109391. [Google Scholar] [CrossRef]
  25. Wan, X.; Wang, D.; Huang, H.; Mao, G.J.; Deng, G.J. Radical-mediated photoredox hydroarylation with thiosulfonate. Chem. Commun. 2023, 59, 2767–2770. [Google Scholar] [CrossRef]
  26. Yang, Z.; Wu, X.; Zhang, J.; Yu, J.T.; Pan, C. Metal-Free Photoinduced Hydrocyclization of Unactivated Alkenes toward Ring-Fused Quinazolin-4(3H)-ones via Intermolecular Hydrogen Atom Transfer. Org. Lett. 2023, 25, 1683–1688. [Google Scholar] [CrossRef]
  27. Singh, J.; Sharma, A. Visible Light Mediated Synthesis of Oxindoles. Adv. Synth. Catal. 2021, 363, 4284–4308. [Google Scholar] [CrossRef]
  28. Gui, Q.-W.; Teng, F.; Li, Z.-C.; **ong, Z.-Y.; **, X.-F.; Lin, Y.-W.; Cao, Z.; He, W.-M. Visible-light-initiated tandem synthesis of difluoromethylated oxindoles in 2-MeTHF under additive-, metal catalyst-, external photosensitizer-free and mild conditions. Chin. Chem. Lett. 2021, 32, 1907–1910. [Google Scholar] [CrossRef]
  29. He, C.; Tang, X.; He, X.; Zhou, Y.; Liu, X.; Feng, X. Regio- and enantioselective conjugate addition of β-nitro α,β-unsaturated carbonyls to construct 3-alkenyl disubstituted oxindoles. Chin. Chem. Lett. 2023, 34, 107487. [Google Scholar] [CrossRef]
  30. Marchese, A.D.; Larin, E.M.; Mirabi, B.; Lautens, M. Metal-Catalyzed Approaches toward the Oxindole Core. Acc. Chem. Res. 2020, 53, 1605–1619. [Google Scholar] [CrossRef]
  31. Song, Q.; Su, J.; Li, X.; Huang, H. Difluorocarbene-Enabled Synthesis of 3-Substituted-2-oxoindoles from o-Vinylanilines. Chin. J. Org. Chem. 2023, 43, 1178–1182. [Google Scholar] [CrossRef]
  32. Wang, H.; **e, Y.; Zhou, Y.; Cen, N.; Chen, W. Catalyst-free, direct electrochemical trifluoromethylation/cyclization of N-arylacrylamides using TfNHNHBoc as a CF3 source. Chin. Chem. Lett. 2022, 33, 221–224. [Google Scholar] [CrossRef]
  33. Wang, X.; Liu, Y.; Lu, B.; Li, F. Dirhodium/Xantphos-Catalyzed Tandem C–H Functionalization/Allylic Alkylation: Direct Access to 3-Acyl-3-allyl Oxindole Derivatives from N-Aryl-α-diazo-β-keto Amides. Chin. J. Org. Chem. 2022, 42, 3390–3397. [Google Scholar] [CrossRef]
  34. Zhang, R.-Y.; Xu, M.-M.; Li, H.-Y.; Xu, X.-P.; Ji, S.-J. Cascade reaction involving intramolecular oxygen-migration: Efficient synthesis of 3-allylidene-indolin-2-one compounds under metal-free conditions. Chin. Chem. Lett. 2021, 32, 433–436. [Google Scholar] [CrossRef]
  35. Leng, H.; Zhao, Q.; Mao, Q.; Liu, S.; Luo, M.; Qin, R.; Huang, W.; Zhan, G. NHC-catalysed retro-aldol/aldol cascade reaction enabling solvent-controlled stereodivergent synthesis of spirooxindoles. Chin. Chem. Lett. 2021, 32, 2567–2571. [Google Scholar] [CrossRef]
  36. Huang, H.; Ji, X.; Zhao, F.; Wu, X. Visible Light-Assisted Photocatalyst-Free Tandem Sulfonylation/ Cyclization for the Synthesis of Oxindoles. Chin. J. Org. Chem. 2022, 42, 4323–4331. [Google Scholar] [CrossRef]
  37. Miao, Z.; Zhang, X.; Liu, Y. Research Progress on the Synthetic Method of Five-Membered Spirooxindole Derivatives at C-3 Position. Chin. J. Org. Chem. 2021, 41, 3965–3982. [Google Scholar] [CrossRef]
  38. Liu, Z.; Zhong, S.; Ji, X.; Deng, G.-J.; Huang, H. Hydroarylation of Activated Alkenes Enabled by Proton-Coupled Electron Transfer. ACS Catal. 2021, 11, 4422–4429. [Google Scholar] [CrossRef]
  39. Liu, Z.; Zhong, S.; Ji, X.; Deng, G.J.; Huang, H. Photoredox Cyclization of N-Arylacrylamides for Synthesis of Dihydroquinolinones. Org. Lett. 2022, 24, 349–353. [Google Scholar] [CrossRef]
  40. Qu, Z.; Tian, T.; Tan, Y.; Ji, X.; Deng, G.-J.; Huang, H. Redox-neutral ketyl radical coupling/cyclization of carbonyls with N-aryl acrylamides through consecutive photoinduced electron transfer. Green Chem. 2022, 24, 7403–7409. [Google Scholar] [CrossRef]
  41. Nicewicz, D.; Roth, H.; Romero, N. Experimental and Calculated Electrochemical Potentials of Common Organic Molecules for Applications to Single-Electron Redox Chemistry. Synlett 2015, 27, 714–723. [Google Scholar] [CrossRef] [Green Version]
  42. Glaser, F.; Kerzig, C.; Wenger, O.S. Multi-Photon Excitation in Photoredox Catalysis: Concepts, Applications, Methods. Angew. Chem. Int. Ed. 2020, 59, 10266–10284. [Google Scholar] [CrossRef] [PubMed]
  43. Xu, J.; Cao, J.; Wu, X.; Wang, H.; Yang, X.; Tang, X.; Toh, R.W.; Zhou, R.; Yeow, E.K.L.; Wu, J. Unveiling Extreme Photoreduction Potentials of Donor-Acceptor Cyanoarenes to Access Aryl Radicals from Aryl Chlorides. J. Am. Chem. Soc. 2021, 143, 13266–13273. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Bioactive molecules containing the oxindole motif.
Figure 1. Bioactive molecules containing the oxindole motif.
Catalysts 13 01007 g001
Figure 2. Cyclization and hydroarylation methods.
Figure 2. Cyclization and hydroarylation methods.
Catalysts 13 01007 g002
Figure 3. Substrate scope of photocyclization of N-arylacrylamides.
Figure 3. Substrate scope of photocyclization of N-arylacrylamides.
Catalysts 13 01007 g003
Figure 4. Competitive cyclization.
Figure 4. Competitive cyclization.
Catalysts 13 01007 g004
Scheme 1. Mechanistic studies.
Scheme 1. Mechanistic studies.
Catalysts 13 01007 sch001
Scheme 2. Possible reaction mechanism.
Scheme 2. Possible reaction mechanism.
Catalysts 13 01007 sch002
Table 1. Optimization of Reaction Conditions a.
Table 1. Optimization of Reaction Conditions a.
EntryPCAdditiveSolventYield of 2a (%) b
14CzIPNDecanaltoluene80
2 c4CzIPNDecanaltolueneNR
3 d4CzIPNDecanaltoluene17
4-DecanaltolueneNR
54CzIPN-tolueneNR
6Rose bengalDecanaltolueneNR
7Mes2AcrtBu2PF6DecanaltolueneNR
8XanthoneDecanaltolueneNR
99-FluorenoneDecanaltolueneNR
10Eosin YDecanaltoluene73
114CzIPNDecanalTHFNR
124CzIPNDecanalDMFNR
134CzIPNDecanalEtOAcNR
144CzIPNDecanalDCENR
154CzIPNDecanalNMPNR
164CzIPNDecanalCH3CNNR
174CzIPNDecanalPhCl65
184CzIPNDecanalo-Xylene70
194CzIPNAldehyde-1toluene40
204CzIPNAldehyde-2toluene67
214CzIPNAldehyde-3toluene33
224CzIPNAldehyde-4toluene57
234CzIPNAldehyde-5toluene61
24 e4CzIPNDecanaltoluene60
Catalysts 13 01007 i001
Catalysts 13 01007 i002
a Reaction conditions: 1a (35 mg, 0.2 mmol), additive (0.2 mmol, 1 equiv), photocatalyst (0.006 mmol), H2O (0.4 mL), solvent (1 mL), under Ar atmosphere, using 35 W blue LED. b Isolated yield of 2a was given, and regioselective ratio of 2a/3a was more than 25/1 in all cases in this table. c In dark. d No water. e 4CzIPN (2 mol%, 0.004 mmol) was used.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Liu, Z.; Ji, X.; Zhao, F.; Deng, G.; Huang, H. Metal-Free Photoredox Intramolecular Cyclization of N-Aryl Acrylamides. Catalysts 2023, 13, 1007. https://doi.org/10.3390/catal13061007

AMA Style

Liu Z, Ji X, Zhao F, Deng G, Huang H. Metal-Free Photoredox Intramolecular Cyclization of N-Aryl Acrylamides. Catalysts. 2023; 13(6):1007. https://doi.org/10.3390/catal13061007

Chicago/Turabian Style

Liu, Zhaosheng, **aochen Ji, Feng Zhao, Guojun Deng, and Huawen Huang. 2023. "Metal-Free Photoredox Intramolecular Cyclization of N-Aryl Acrylamides" Catalysts 13, no. 6: 1007. https://doi.org/10.3390/catal13061007

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop